StemSight
StemSight cures severe corneal blindness with an off-the-shelf stem cell therapy - new treatments for blindness by differentiating cell therapies from human pluripotent stem cells.
Tampere, Finlandwww.stemsight.fi ↗
Total raised
€2.8M
€2,800,000
Funding rounds
2
Investors
6
distinct backers
Active since
2021-09
latest 2025-02
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood37
base rate 30% for Other
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood12
base rate 12% (2+ rounds)
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-02-13 | Other | €2.3M | Biothom Oy,Business Finland,Private Investors,Stephen Industries Inc. ,Voima Ventures | View deal → |
| 2021-09-13 | Pre-Seed | €500k | Avohoidon Tutkimussäätiö,Voima Ventures | View deal → |
Investors
6Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Iceye€1.5BFinland · Space
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Nokia€859MFinland · Telecom